Pain News and Research

Latest Pain News and Research

Gaining weight during pregnancy causes increased risk for tears during delivery

Excessive weight gain during pregnancy significantly increases the risk of lacerations during vaginal childbirth, according to a study conducted by researchers at Montefiore Medical Center.

8 May 2013

Academy of Nutrition and Dietetics encourages people to learn about celiac disease

Celiac disease is estimated to affect one out of 141 of Americans, or just under 1 percent of the population.

8 May 2013

Clinical data of cabozantinib to be presented at ASCO meeting

Exelixis, Inc. announced today that cabozantinib will be the subject of nine separate data presentations at the upcoming 2013 Annual Meeting of the American Society of Clinical Oncology.

8 May 2013

Advances in lung cancer treatment have major impact on short- and long-term outcomes

The American College of Chest Physicians third edition of evidence-based lung cancer guidelines, Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, recommends offering low-dose computed tomography scanning for lung cancer screening to people with a significant risk of lung cancer due to age and smoking history.

8 May 2013

Nuvo Research intends to proceed with its proposed share consolidation

Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.

7 May 2013

Bayer honours Canadians who have made a mark on society through science and innovation

Scientists and innovators have guided every step in Bayer's 150-year journey to becoming a global leader in healthcare, crop and material sciences. As it marks its 150th anniversary this year, Bayer also celebrates Canadian innovation and individuals who exemplify the curiosity and commitment to help shape a better future.

7 May 2013

American Pain Society to host Annual Scientific Meeting in New Orleans from May 8 to 11

The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.

7 May 2013

Study; Media reports about supposedly hazardous substances may trigger nocebo effect in some people

Media reports about substances that are supposedly hazardous to health may cause suggestible people to develop symptoms of a disease even though there is no objective reason for doing so.

7 May 2013

Researchers publish new Canadian guidelines for diagnosis and treatment of fibromyalgia

Physicians from the McGill University Health Centre (MUHC) and the University of Calgary have published a review article in the CMAJ (Canadian Medical Association Journal) to help family doctors diagnose and treat fibromyalgia.

7 May 2013

"Minimalist" shoes allow runner to imitate barefoot running, protect sole and toe

For tens of thousands of years, humans ran on bare feet. Then we developed an assortment of specialized shoes, including - particularly since the 1960s - a seemingly limitless variety of running shoes.

6 May 2013

Clinical trial recruits patients with lower back pain to investigate non-surgical treatment

A clinical trial being conducted at the University of British Columbia, sponsored by Active-O, is currently recruiting patients suffering from lower back pain caused by a contained herniated disc to investigate a new, non-surgical treatment.

6 May 2013

Australia approves Fziomed’s new viscoelastic gel

FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the inclusion of Dynavisc on the Australian Register of Therapeutic Goods (ARTG).

From Medtronic 6 May 2013

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

Cancer chemotherapy can cause peripheral neuropathy-nerve damage often resulting in pain and muscle weakness in the arms and legs. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that chemo also induces an insidious type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation.

6 May 2013

New physical exercise programme improves muscle strength and balance in women with osteoporosis

Montserrat Otero, a UPV/EHU lecturer, has concluded that physical exercise done with basic materials improves muscle strength and balance in women with osteoporosis

6 May 2013

New protocol for reducing the use of SPECT SPI is found to be diagnostically safe

A new stress test protocol that investigates reducing the use of perfusion imaging in low risk patients undergoing SPECT myocardial perfusion imaging for possible angina symptoms was found to be diagnostically safe, revealed a US retrospective analysis.

6 May 2013

Scioderm gets Breakthrough Therapy designation for SD-101 from FDA for treatment of EB

Scioderm announced its investigational product SD-101 has received Breakthrough Therapy designation by the U.S. Food and Drug Administration for the treatment of patients with inherited Epidermolysis Bullosa.

5 May 2013

Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UC San Francisco researchers have discovered, raising hope that these cells might one day be used to treat people with Parkinson's disease, epilepsy, and possibly even Alzheimer's disease, as well as and complications of spinal cord injury such as chronic pain and spasticity.

5 May 2013

Viewpoints: Liberals refuse to acknowledge evidence of Oregon Medicaid study; Politics is roiling science in emergency contraception decisions

A familiar critique of liberal governance is that the results always matter less than its grand social ambitions. The latest evidence of this truth comes in the reaction to disappointing new findings from one of the most important public-policy experiments since the 1970s. A team of varsity health economists, mostly at Harvard and MIT, is studying the relationship between health outcomes and health insurance delivered by Medicaid (5/2).

4 May 2013

New FDA-approved method for detecting diabetic neuropathy

Details of a new method to detect diabetic neuropathy in patients in less than five minutes using their sweat glands was presented today at the American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress in Phoenix, Arizona by Aaron I. Vinik, M.D., Ph.D., F.C.P., M.A.C.P., F.A.C.E., Professor of Medicine and Director of Research and the Neuroendocrine Unit at Eastern Virginia Medical School.

4 May 2013

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

4 May 2013

Pain News and Research

Latest Pain News and Research

Gaining weight during pregnancy causes increased risk for tears during delivery

Academy of Nutrition and Dietetics encourages people to learn about celiac disease

Clinical data of cabozantinib to be presented at ASCO meeting

Advances in lung cancer treatment have major impact on short- and long-term outcomes

Nuvo Research intends to proceed with its proposed share consolidation

Bayer honours Canadians who have made a mark on society through science and innovation

American Pain Society to host Annual Scientific Meeting in New Orleans from May 8 to 11

Study; Media reports about supposedly hazardous substances may trigger nocebo effect in some people

Researchers publish new Canadian guidelines for diagnosis and treatment of fibromyalgia

"Minimalist" shoes allow runner to imitate barefoot running, protect sole and toe

Clinical trial recruits patients with lower back pain to investigate non-surgical treatment

Australia approves Fziomed’s new viscoelastic gel

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

New physical exercise programme improves muscle strength and balance in women with osteoporosis

New protocol for reducing the use of SPECT SPI is found to be diagnostically safe

Scioderm gets Breakthrough Therapy designation for SD-101 from FDA for treatment of EB

Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

Viewpoints: Liberals refuse to acknowledge evidence of Oregon Medicaid study; Politics is roiling science in emergency contraception decisions

New FDA-approved method for detecting diabetic neuropathy

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in